trial · primary record
ALLO-329
Systemic Lupus Erythematosus (With and Without Nephritis)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2032-10 |
| Primary endpoint | Incidence of Dose Limiting toxicities (DLTs) and Other Safety Parameters |
| Registry ID | NCT07085104 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:10.074Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07085104
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.